Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

How EvoLV Leverages Local Expertise to Benefit Life Sciences Clients

Jul 27, 2025

Harnessing Local Expertise for Global Impact

In the rapidly evolving field of life sciences, staying ahead of the curve requires not only innovation but also a deep understanding of local markets and regulations. EvoLV stands out by leveraging local expertise to deliver tailored solutions that benefit their life sciences clients. This approach ensures that clients can navigate complex landscapes with ease and precision.

By tapping into regional knowledge, EvoLV provides a unique advantage, allowing clients to optimize their strategies and operations in diverse geographical areas. This localized approach is not just about meeting regulatory requirements but also about understanding cultural nuances and market dynamics that can influence success.

local business

Understanding Regional Regulatory Landscapes

One of the significant challenges in the life sciences sector is navigating the intricate regulatory environments across different regions. EvoLV's team comprises experts who are well-versed in local regulations, ensuring that clients remain compliant while accelerating their market entry.

This regional expertise means that EvoLV's clients can avoid common pitfalls associated with regulatory compliance, reducing the risk of costly delays and penalties. By staying updated with the latest changes in regional policies, EvoLV helps clients make informed decisions that align with both local laws and global standards.

Cultural Sensitivity and Market Insights

Beyond regulatory considerations, understanding cultural dynamics is crucial for successful market penetration. EvoLV's local experts offer valuable insights into consumer behavior and preferences, enabling life sciences companies to tailor their products and marketing strategies effectively.

Whether it's adapting communication styles or modifying product features to suit local tastes, this cultural sensitivity ensures that clients can resonate with their target audiences. This approach not only boosts brand loyalty but also enhances market acceptance and growth.

market analysis

Building Local Partnerships

Another strength of EvoLV's approach is its commitment to building strong local partnerships. By collaborating with local stakeholders, including healthcare providers, academic institutions, and regulatory bodies, EvoLV facilitates smoother operations and fosters innovation.

These partnerships are instrumental in driving collaborative research initiatives and clinical trials, offering clients access to cutting-edge developments in the life sciences field. This network of local alliances amplifies the resources and expertise available to EvoLV's clients.

Customized Solutions for Diverse Needs

EvoLV understands that each client has unique needs and challenges. By leveraging local expertise, they offer customized solutions that address specific regional issues while aligning with the client's broader business goals.

From strategic planning to operational execution, EvoLV ensures that their clients receive personalized support that maximizes their potential in each market. This bespoke service model is a testament to EvoLV's commitment to client success.

teamwork success

Conclusion: A Winning Strategy for Life Sciences

In an industry as dynamic as life sciences, EvoLV's strategy of leveraging local expertise proves to be a winning formula. By combining global knowledge with regional insights, EvoLV empowers its clients to thrive in complex environments.

As life sciences companies continue to expand their global footprint, partnering with a firm like EvoLV offers the assurance of not only compliance but also competitive advantage. With local experts guiding the way, clients can confidently navigate new territories and achieve sustainable growth.